About
Imagion Biosystems Ltd (AU:IBX) — investor relations, events, news, and company updates on 6ix.
Latest News
Feb 27 2026
FY25 Appendix 4E and Annual Report
Feb 3 2026
Medical-imaging company Imagion Biosystems Lodges IND with FDA for Phase 2 Trial of MagSense® HER2 targeted imaging agent
Feb 2 2026
IBX's IND Application Lodged with FDA for HER2 Phase 2 Trial
Jan 29 2026
Appendix 4C and Quarterly Activities Report - December 2025
Jan 8 2026
Mercer Convertible Securities Conversion and Amendment
Translate